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This is the third edition of a very reputable book that was first
written by Vincent Riccardi and Jan Eichner in 1986, prior to
the molecular explosion in human genetics. The first edition
represented the most comprehensive review of neurofibro-
matosis (NF) literature at that time, with proposed categori-
zation based on the variable expression seen in these disorders.
The second edition (written by Riccardi in 1992) was also a
seminal volume, in terms of medical literature review by organ
system, insight about underlying mechanisms, and information
about the newly cloned NF1 gene. For the third edition, Dr.
Riccardi is joined by three well-respected physician-scientists
(Jan Friedman, David Gutmann, and Mia MacCollin) as ed-
itors. This edition is a welcome update, but it has diverged in
format. Instead of one author writing multiple sections based
mostly on organ systems, the medical information is somewhat
reorganized into chapters written by contributing authors, all
of whom are active, established investigators (and, in nearly
all cases, physicians) in NF. This altered structure was likely
necessary because of the vast increase in knowledge in the NF1
and NF2 fields. To include this new information, the pages
devoted to clinical descriptions have been reduced, to focus
on the most important and well-described medical aspects of
NF; however, coverage of the relevant genetic and cell biology
advances in both NF1 and NF2 has increased. Furthermore,
in the second edition, all the references were listed together
alphabetically at the back of the book, providing a single, large
literature-search listing. In the third edition, the references are
placed at the end of each chapter, which is traditional for
multiauthored books but not quite as helpful for some uses.
It is very difficult for any physician or investigator to be fa-
miliar with all the NF1 and NF2 literature, since there are
literally hundreds of articles, across the spectrum of work,
being published each year. Overall, the authors do a creditable
job of referencing and summarizing the most current and med-
ically relevant progress, given that, because of space issues,
only a portion of the relevant NF literature can be discussed.
This volume provides excellent illustrations of clinical fea-
tures and clinical and scientific data. Some of the chapters offer
“future directions” (or similar reference to needs and directions
of clinical and basic research). These paragraphs provide an
insightful overview on what is known and what we need to
know. lso included are recommendations from clinical task
forces that have been created to specifically study areas such
as pilocytic astrocytoma (optic-pathway glioma) in NF1. Re-
cent clinical data from NF databases, which contain infor-
mation from many patients, are provided to add to the current
literature and to increase confidence in clinically relevant sta-
tistics, such as frequencies of features and severity. Thus, this
book will likely be widely used by physicians in all specialties,
as the most current guideline for clinical management of NF
and as a source for finding further information. To summarize
the current understanding of cognitive deficits in NF1, an un-
derstanding that is greatly expanded compared with the prior
edition, the chapter by Kathryn North draws cognitive and
molecular/pathogenetic/animal model data together. This will
benefit researchers as well as professionals such as psycholo-
gists and educators. Investigators in the many areas of NF1
and NF2 research will also find this to be a useful reference,
since it is the most up-to-date publication bringing together
clinical data and basic science knowledge. There are a few
other helpful touches, such as David Viskochil’s glossary at
the end of the NF1-gene chapter. Although this work is not
primarily intended for a lay audience, some features were de-
signed for the public (e.g., the Appendix lists resources [in-
cluding Web sites] for patients). Given both the relatively high
frequency of NF in the general population and the increasing
recognition of and interest in these disorders, this book will
effectively serve both professionals and patients.
MARGARET R. WALLACE
Pediatric Genetics
University of Florida
Gainesville
 2000 by The American Society of Human Genetics. All rights reserved.
0002-9297/2000/6701-0039$02.00
Am. J. Hum. Genet. 67:264–266, 2000
Genes, Peoples, and Languages. By Luigi Luca Cavalli-
Sforza. New York: Farrar, Straus & Giroux, 2000. Pp.
224. $24.00 (hardcover).
The human past has traditionally been reconstructed on the
basis of written records and archaeological evidence. It was
